Ebola Virus To Uganda Threatening International Health

Ebola is primarily an animal disease, with the virus taking shelter in bats and other mammals. It may spill over into the human population when someone eats an infecting bat, for instance. However, such events usually end spontaneously with a chain of not more than 5 people; Study in the spreading of Ebola virus to Uganda threatening international health.

Where nearly 1,000 people are dieing, the deadly Ebola virus crossing the border to Uganda in June 2109; This virus causing sudden high fever and sore throat; with severe weakness and muscle pain.Ebola virus, it quickly progresses to vomiting and diarrhea; with signs of internal and external bleeding; transmitting through the contact with body fluid from an infected person.

Ebola virus

By identifying, and advising to the remaining at the home to be vaccinating against the disease; which is initiating since the DRC outbreak begning; There being no mass gatherings, and information about the disease is being broadcasting continuously.

But nearly 4,000 health workers are receiving vaccination, and screening camps are operating all along the border with DRC; and other major portals.Having high risk because of high people mobility and proximity to the border are being monitoring constantly for spot diagnosis and management of any cases.Uganda will begin ring immunization on June 14 to contain the spread of the virus by immunizing direct contacts and their contacts.

Doses of Ebola vaccine

A rapid response team is already in place to identify those at high risk. 400 doses of Ebola vaccine have been sent in by the DRC with another 4,000 doses from the WHO. This new vaccine prevents infection in almost 98% of cases; research finding that comparing to the reporting size of the outbreak in these places, only about 17% to 48% were actually reporting.

However, by clinically recognizing outbreaks include only symptomatic cases, and if over 80% of single cases or small outbreaks are missing; this could be the reason for the presence of these antibodies; where the early detection of outbreaks is critical to timely response, but estimating detection rates is difficult because unreported spillover events and outbreaks do not generate data.